Chief investigatorRury Holman
Sponsor:University of Oxford
Funder:Diabetes Trials Unit, University of Oxford
The RMM study aimed to examine the ability of an established telehealth mood monitoring system (True Colours) to evaluate the impact on mood of initiating an injectable therapy in individuals with type 2 diabetes.
Pilot proof-of-concept non-interventional questionnaire study seeking to record possible mood changes in people with type 2 diabetes when first starting an injectable diabetes therapy.
The study showed that an online self-management system could be used to monitor mood remotely in people with type 2 diabetes and could provide additional metrics to help guide diabetes management. The results are currently being submitted for publication.
No news articles exist